ArticleOpen forum infectious diseases2022

One in 10 Virally Suppressed Persons With HIV in The Netherlands Experiences ≥10% Weight Gain After Switching to Tenofovir Alafenamide and/or Integrase Strand Transfer Inhibitor.

Myrthe L Verburgh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.